Carlos G. Romo

1.0k citations
49 papers · 560 indexed · h-index 11

Carlos G. Romo

45 papers receiving 548 citations

Peers

Carlos G. Romo
Comparison fields: 5 of 70
  • Genetics 338
  • Hematology 279
  • Rheumatology 142
  • Neurology 60
  • Small Animals 24
Replace Kaveri Suryanarayan with:
Kaveri Suryanarayan United States
R Morgan United States
Jennifer Willert United States
Yoshihito Hayami Japan
Kwesi Sackey Saudi Arabia
Ingrid L. M. Wolvers‐Tettero Netherlands
Gary S. Lissner United States
Simonetta Kerim Italy
Martine Jotterand Switzerland
Erica Campagnaro United States
Carlos G. Romo relative to Kaveri Suryanarayan United States Kaveri Suryanarayan's profile →
Citations per field
00.5×
Kaveri Suryanarayan · 1×
Citations per year

Countries citing papers authored by Carlos G. Romo

Since Specialization
Citations

This map shows the geographic impact of Carlos G. Romo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos G. Romo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos G. Romo more than expected).

Fields of papers citing papers by Carlos G. Romo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos G. Romo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos G. Romo. The network helps show where Carlos G. Romo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carlos G. Romo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carlos G. Romo Line = papers co-authored together Carlos G. Romo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20252
3 20251
4 20241
5 20245
6 20242
7 20232
8 20236
9 20232
10 20236
11 20235
12 20232
13 20231
14 20234
15 20236
16 20231
17 20221
18 20204
19 201910
20 201138

About Carlos G. Romo

Carlos G. Romo is a scholar working on Genetics, Neurology, Hematology, Rheumatology and Structural Biology, having authored 49 papers that have together received 560 indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (18 papers), Glioma Diagnosis and Treatment (13 papers), Soft tissue tumor case studies (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Neuroblastoma Research and Treatments (6 papers), Sarcoma Diagnosis and Treatment (5 papers) and Brain Metastases and Treatment (4 papers). The work is most often cited by research in Genetics (338 citations), Hematology (279 citations), Rheumatology (142 citations), Neurology (60 citations) and Small Animals (24 citations). Carlos G. Romo has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Preetesh Jain, Jörge E. Cortes, Susan O’Brien, Hagop M. Kantarjian, Elias Jabbour, Gautam Borthakur, Farhad Ravandi, Alfonso Quintás‐Cardama, Marylou Cárdenas-Turanzas and Aziz Nazha. Their work appears in journals such as Blood, Journal of Investigative Dermatology, Neuro-Oncology, Journal of Clinical Oncology and JAMA Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026